 DEER PARK, Ill., Oct. 18, 2022 GLOBE NEWSWIRE -- Eton Pharmaceuticals Eton or the Company Nasdaq: ETON, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean Brynjelsen, Chief Executive Officer, will present at the LD Micro Main Event XV Conference as follows: 